Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma (Q44356441)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 November 2014
edit
Language Label Description Also known as
English
Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma
scientific article published on 21 November 2014

    Statements

    Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma (English)
    21 November 2014
    195-204

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit